SCHEMBL38381

SCHEMBL38381

NS(=O)(=O)c1cc2nc(Cc3ccc(Cl)c(Cl)c3)[nH]c(=O)c2s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 2/20 0.47
RNASEH1 O60930 1/20 0.47
RAB9A P51151 3/20 0.41
KDM4E B2RXH2 2/20 0.41
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PNP P00491 1/20 0.39
TYMP P19971 1/20 0.39
TYMS P04818 1/20 0.38
ALDH1A1 P00352 3/20 0.37
HPGD P15428 2/20 0.37
ALOX12 P18054 1/20 0.37
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
SLC6A3 Q01959 2/20 0.37
CYP3A4 P08684 1/20 0.36
POLB P06746 1/20 0.36
HTT P42858 1/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL37644 0.89 PDE5A (0.53) PDE5ARNASEH1RAB9AKDM4ELMNA
SCHEMBL37584 0.86 PDE5A (0.66) PDE5ARAB9AKDM4ELMNASMN1; SMN2
SCHEMBL38180 0.77 PDE5A (0.60) PDE5ARNASEH1RAB9AKDM4ELMNA
SCHEMBL38312 0.76 PDE5A (0.70) PDE5ARAB9AKDM4ELMNASMN1; SMN2
SCHEMBL37850 0.76 RNASEH1 (0.47) PDE5ARNASEH1RAB9AKDM4ELMNA
SCHEMBL38977 0.74 RNASEH1 (0.49) PDE5ARNASEH1RAB9AKDM4ELMNA
SCHEMBL44521 0.74 RAB9A (0.45) PDE5ARNASEH1RAB9AKDM4ELMNA
SCHEMBL38484 0.74 PDE5A (0.57) PDE5ARNASEH1RAB9AKDM4ELMNA
SCHEMBL46456 0.74 PDE5A (0.57) PDE5ARNASEH1RAB9AKDM4ELMNA
SCHEMBL38179 0.74 PDE5A (0.46) PDE5ARNASEH1RAB9AKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012004900-A1 THIENOPYRIMIDINE COMPOUNDS ASKA PHARMACEUTICAL CO., LTD. (JP) 2012-01-12 WO disclosed